These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3065601)

  • 1. Myopathies caused by disorders of lipid metabolism.
    Carroll JE
    Neurol Clin; 1988 Aug; 6(3):563-74. PubMed ID: 3065601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.
    Laforêt P; Vianey-Saban C
    Neuromuscul Disord; 2010 Nov; 20(11):693-700. PubMed ID: 20691590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myopathies caused by defects of lipid and carbohydrate metabolism].
    Angelini C; Martinuzzi A; Micaglio G; Vergani L
    Riv Neurol; 1988; 58(1):15-25. PubMed ID: 3047844
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency.
    Turnbull DM; Bartlett K; Stevens DL; Alberti KG; Gibson GJ; Johnson MA; McCulloch AJ; Sherratt HS
    N Engl J Med; 1984 Nov; 311(19):1232-6. PubMed ID: 6493275
    [No Abstract]   [Full Text] [Related]  

  • 6. Disorders of lipid metabolism in muscle.
    Di Mauro S; Trevisan C; Hays A
    Muscle Nerve; 1980; 3(5):369-88. PubMed ID: 7421873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood.
    Rocchiccioli F; Wanders RJ; Aubourg P; Vianey-Liaud C; Ijlst L; Fabre M; Cartier N; Bougneres PF
    Pediatr Res; 1990 Dec; 28(6):657-62. PubMed ID: 2284166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels.
    Liebig M; Schymik I; Mueller M; Wendel U; Mayatepek E; Ruiter J; Strauss AW; Wanders RJ; Spiekerkoetter U
    Pediatrics; 2006 Sep; 118(3):1065-9. PubMed ID: 16950999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy.
    Westermann CM; Dorland L; Votion DM; de Sain-van der Velden MG; Wijnberg ID; Wanders RJ; Spliet WG; Testerink N; Berger R; Ruiter JP; van der Kolk JH
    Neuromuscul Disord; 2008 May; 18(5):355-64. PubMed ID: 18406615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carnitine deficiency myopathy: a case of late diagnosis].
    Rico Corral MA; de la Vega Vázquez JM; Holgado Silva C; Aznar Martín A; Zamora Madaría E
    An Med Interna; 2002 Aug; 19(8):415-8. PubMed ID: 12244790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The syndrome of carnitine deficiency.
    Di Donato S; Cornelio F
    Riv Patol Nerv Ment; 1976 Aug; 97(4):181-5. PubMed ID: 1032033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases.
    Wasant P; Matsumoto I; Naylor E; Liammongkolkul S
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S710-9. PubMed ID: 12403251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alterations of mitochondria in metabolic diseases. Carnitine deficiency, carnitine palmitoyltransferase deficiency and beta oxidation].
    Angelini C
    Acta Neurol (Napoli); 1989 Oct; 11(5):330-4. PubMed ID: 2603779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid storage myopathies.
    Bruno C; Dimauro S
    Curr Opin Neurol; 2008 Oct; 21(5):601-6. PubMed ID: 18769256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase.
    Clark-Taylor T; Clark-Taylor BE
    Med Hypotheses; 2004; 62(6):970-5. PubMed ID: 15142659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis caused by an inherited metabolic disease: very long-chain acyl-CoA dehydrogenase deficiency.
    Voermans NC; van Engelen BG; Kluijtmans LA; Stikkelbroeck NM; Hermus AR
    Am J Med; 2006 Feb; 119(2):176-9. PubMed ID: 16443431
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myopathies related to lipid metabolism disorders (review of the literature)].
    Aingorn ED; Zhurba LT; Koroleva IA; Timonina OV; Sitnikov VF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(10):1441-4. PubMed ID: 494923
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
    Laforêt P; Acquaviva-Bourdain C; Rigal O; Brivet M; Penisson-Besnier I; Chabrol B; Chaigne D; Boespflug-Tanguy O; Laroche C; Bedat-Millet AL; Behin A; Delevaux I; Lombès A; Andresen BS; Eymard B; Vianey-Saban C
    Neuromuscul Disord; 2009 May; 19(5):324-9. PubMed ID: 19327992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.